|
 |
AllerganThis page contains recent news articles, when available, and an overview of Allergan but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.London—BTG plc has licensed to Allergan exclusive worldwide rights to develop products for eye diseases and conditions using BTG's drug delivery system ... ModernMedicine Botox Injury Lawsuit Set for Trial - 06 Jan 2010 Later this month, a Southern California jury is scheduled to hear a lawsuit filed against Allergan Inc., the maker of the blockbuster drug Botox, ... Attorney at Law RevitaLash - 06 Jan 2010 In August, 2009, Athena Cosmetics filed a lawsuit against Allergan, creators of prescription-only eyelash product Latisse. Since creating RevitaLash, Athena ... Truth In Aging (blog) Defensives Still Offer Value Here - 06 Jan 2010 How about Allergan (AGN - commentary - Trade Now) and Abbott (ABT - commentary - Trade Now)? They have big eye care divisions, which is the attraction on ... TheStreet.com (blog) One in the Eye for Alcon Investors - Jan 4, 2010 That is a wide premium to the 10 times and 15 times multiples for the medical-equipment sector, and above the 12 times and 20 times at rival Allergan. ... Wall Street Journal Allergan CEO sounds off on Botox tax - Dec 13, 2009 Not surprisingly, companies like Allergan Inc. (NYSE:AGN) , a leading marketer of breast implants and the wrinkle-battlers Botox and Juvederm, has declared ... MarketWatch Pieris Appoints a New CEO - Jan 4, 2010 ..."With our recent collaboration with Allergan focusing on ocular disorders and our Phase I study for PRS-050, our proprietary anti-VEGF Anticalin program, ... PR Newswire (press release) Investing in seniors' golden years - Jan 4, 2010 At the top of the list are health care-related stocks, such as Allergan (AGN), which makes Botox, the frown line smoother, and Ozurdex, the first drug to ... Washington Examiner Guideline Nixes TENS for Chronic Low Back Pain - Dec 30, 2009 Dubinsky reported serving on a scientific advisory board and speakers bureau for Allergan, and receiving honoraria from BrioMed and research support from ... MedPage Today BTG Licenses ReGel To Allergan To Develop Products For Eye Diseases - Update - Dec 18, 2009 L: News ) Friday said that it has licensed exclusive worldwide rights to Allergan Inc. (AGN: News ), a multi-specialty healthcare company based in Irvine, ... RTT News Cosmetic Surgery Tax Out, Tanning Tax In For Sen Health Bill - Dec 19, 2009 ...based Allergan , maker of Botox, led a lobbying campaign to kill the cosmetic surgery tax, including a Web site, Twitter feed and Facebook campaign. ... CNNMoney.com 2009 Reader's Choice - Top 5 Injectables and Fillers - Jan 4, 2010 Others freeze the muscles responsible for forming creases, which diminishes wrinkle appearance 1 - Botox: BOTOX Cosmetic from Allergan uses a form of the ... American Health and Beauty (press release) Allergan Sticks It to Tanning Centers: "Botax" Axed in Favor of Sun Bed Levy - Dec 28, 2009 Tanning parlor owners and the customers they serve can blame Allergan (AGN) CEO David Pyott for the new 10 percent tax they ... BNET Brean Murray Initiates Coverage on Allergan (AGN) with a Buy - Dec 17, 2009 Allergan, Inc. is a multi-specialty health care company focused on developing and commercializing pharmaceuticals, biologics and medical devices. StreetInsider.com (subscription) Allergan announces development plans for ophthalmic drug delivery devices - Dec 22, 2009 Allergan has announced plans to develop drug delivery devices for use in ophthalmology based on a platform designed by BTG. Under the terms of the licensing ... OSN SuperSite Allergan leads fight against Botax - Dec 10, 2009 Allergan is lobbying against the proposed “Botaxâ€?—the proposed 5% tax on elective cosmetic procedures, including Botox. However, the cosmetic company does ... Grinza Brighter Bay LLC launches ophthalmology job recruiting services for eye career ... - Jan 4, 2010 While at Allergan, one of the leading specialty pharmaceutical companies in eye care, Ali built teams that drove top revenue dollars for the corporation. ... PR Urgent It's a love/hate thing Many women swear it works, but the drug, developed to ... - Dec 16, 2009 In September, the FDA sent a warning letter to Allergan stating that side effect information in the Frequently Asked Questions and About Safety sections of ... Chicago Tribune Defiant Year - Jan 1, 2010 Locally, only Irvine drug maker Allergan Inc. added more in market value with an $8 billion gain. Western Digital's big Wall Street jump and its ... Orange County Business Journal Defending tax-free Botox - Dec 13, 2009 A Senate measure would make it pricier to get the anti-wrinkle procedure, sparking a fight with Allergan's CEO. MarketWatch Bat your eyes: Latisse prescription enhances eyelashes - Dec 23, 2009 Many products claim to improve eyelash thickness and appearance, but Latisse Allergan (bimatoprost ophthalmic solution) 0.03 percent is the first and only ... The Ann Arbor News - MLive.com Climate Registered Program Recognizes Voluntary GHG Cuts - Dec 15, 2009 Eastman Kodak, Allergan, Pacific Gas & Electric and Sierra Nevada Brewing Co., among others, have signed on as charter members of the new Climate Registered ... Environmental Leader Diedrich is 2009's Big Stock; Western Digital Takes Prize by Size - Dec 30, 2009 The company added $7 billion in market value in 2009, a feat only topped by Irvine drug maker Allergan Inc. with an $8 billion gain. Allergan is up 60% to ... Orange County Business Journal Cosmetic doctors foresee new techniques in 2010 - Jan 4, 2010 Irvine-based Allergan is one of the two main manufacturers of breast implants. Breast implant business is way down and we see in Europe and Asia an influx ... Around Disney (blog) Oh the Agony! No Public Option and There's a Botox Tax! - Dec 17, 2009 This morning I got a frantic email from Allergan, the manufacturers of Botox and Juvederm injectibles–the former stops wrinkles by temporarily paralyzing ... Firedoglake (blog) Potential tanning tax develops concern in the industry - Jan 4, 2010 The New York Times reported one such example, StopCosmeticTax.org, which was financed in part by Allergan, maker of Botox. Dr. David M. Pariser, ... Naples Daily News Local doctor part of pioneering breast implant surgery - Dec 19, 2009 He's one of only 120 doctors in the nation participating in the review of the Allergan Corporation's 410 highly-cohesive silicone breast implant. ... Hannibal.net High-frequency cyclosporine dosing regimen improves treatment of severe dry eye - Dec 29, 2009 Mean duration of twice-daily Restasis (cyclosporine ophthalmic emulsion 0.05%, Allergan) dosing was 5.2 months before initiation of high-frequency dosing. ... OSN SuperSite The Botax lobby - Dec 14, 2009 Allergan is leading the lobby against the Senate's proposal. The company has even launched a website dedicated to the petition drive. ... Grinza Global Medtech Companies and Medtech Investors Will Disclose Investment, M&A ... - Jan 4, 2010 ...the following companies: Aberdare Ventures - Abingworth Management - Advanced Technology Ventures - Agate Medical Investments - Allergan - Alta Partners ... Market Wire (press release) Tampa Dermatologist Pushes Anti 'Botax' Petition - Dec 15, 2009 The petition was created by Allergan, makers of the cosmetic fillers Botox and Juvaderm. “Adding new taxes is not going to help the economy or our ... Grinza St. Elizabeth Healthcare Reveals an Organization That's Better Together - Jan 4, 2010 Founded by American design icon Donald Deskey, the firm's client roster includes Allergan, Fifth Third Bank, Starbuck's, and a 50-year relationship with ... PR Web (press release) Upgrades & Downgrades: Working on the Railroads - Dec 17, 2009 Allergan (AGN): Frozen smiles all round at Allergan, the Botox maker initiated at Buy by Brean Murray. Intrepid Potash (IPI): The stock is picked up at a ... Minyanville.com Healthcare shares rise as US reform bill progresses - Dec 21, 2009 Shares of Allergan Inc (AGN.N), maker of the anti-wrinkle treatment Botox, rose 1.7 percent to $61.68 after it dodged a bullet that would have placed a 5 ... Reuters Healthcare shares rising due to US reform bill - Dec 31, 2009 Even on the cosmetic side of the industry, shares have rose, namely with Allergan Inc, which manufactures Botox. News of a 5 per cent tax on cosmetic ... Money Market Worldspan Group suffers 14% drop in turnover - Dec 17, 2009 In recent months, Worldspan Events maintained its place on BT's agency roster and won a three-year place on the event management roster of Allergan, ... CIT Magazine Ricky Gervais and Chrissie Hynde Join BUAV Call to End Shocking and Cruel ... - Dec 15, 2009 ...of mice for botox testing and is calling on botox manufacturers such as Ipsen, Allergan and Merz-Pharma, to put an end to this appalling cruelty. ... PR Newswire (press release) Bariatric Nurse Consultant Joins Streamline Surgical - Dec 14, 2009 She later attended the Allergan® Surgeons' course in New York City and the Allergan® Advanced Course in Chicago enabling her to teach multidisciplinary ... BigNews.biz (press release) Reform Could Be 2010's Big Story; Devices in Works, Hoag Expanding - Dec 12, 2009 And Irvine's Allergan Inc. and others are fighting a proposal to tax cosmetic medical procedures that would raise $6 billion in 10 years. ... Orange County Business Journal Unusual Options Activity Review - CVH, AGN, CVS, PALM, SVU, SY, TECD, SAP ... - Dec 18, 2009 Bullish order flow was also seen in Allergan (AGN), CVS, and PALM. Super Value (SVU) slumped 23 cents to $12.60 and options volume hit 2X the average daily, ... The Options Insider Health Insurers Win Delay on Start of $70 Billion in Added Fees - Dec 19, 2009 Allergan Inc., maker of the wrinkle-smoother Botox and silicone breast implants, scored a victory as senators dropped a proposed tax on cosmetic procedures. ... Bloomberg Bill's tax on indoor tanning worries Dallas salon owners - Dec 25, 2009 American Medical Association, American Society of Plastic Surgeons and Botox-maker Allergan – persuaded Congress to remove a tax on cosmetic medical ... Dallas Morning News Latisse proving popular despite recession - Dec 15, 2009 Latisse has been on the market for around one year and helps to make eyelashes longer, thicker and darker, according to pharmaceutical company Allergan. ... Private Healthcare UK SmarTrend's Trend Spotter See Continued Upward Momentum on Shares of Allergan ... - Dec 22, 2009 In approximately 2 months, Allergan has returned 6% as of today's recent price of $61.99. Allergan is currently above its 50-day moving average of $58.54 ... Trading Markets (press release) Giving up Botox - Jan 1, 2010 Plus, according to a spokesman from Allergan, a Californian pharmaceutical company that produces Botox, it turns out the European packaging has carried a ... Financial Times Top Picks for 2010: Fidelity Select Health Care (FSPHX) - Jan 2, 2010 ..."Yoon's top ten holdings are Covidien, Pfizer, Medco Health Solutions, Allergan, Merck, Express Scripts, Baxter Intl., Amgen, Illumina, and Bard. ... BloggingStocks (blog) SmarTrend's Candlestick Scanner Detects Bearish Engulfing Pattern for Allergan ... - Dec 17, 2009 Dec 17, 2009 (SmarTrend(R) Spotlight via COMTEX) ----SmarTrend's candlestick pattern scanner has detected a bearish engulfing pattern for shares of Allergan ... FOXBusiness Botox bull sees Allergan breakout-12/14/2009 - Dec 14, 2009 Botox maker Allergan is getting ready to break resistance, and one investor is fine-tuning a position to take profits and maximize gains. ... NASDAQ Denver Cosmetic Surgeon Hails Bo-Tax Elimination In Final Health Care Reform - Dec 29, 2009 Botox Cosmetic is the trade name of the prescription medicine developed and marketed by the pharmaceutical company Allergan, Inc. Derived from the same ... PR Web (press release) Beta-Amyloid Inhibitor Fails in Alzheimer's Trial - Dec 15, 2009 Wyeth, Abbott Laboratories, Allergan, Allon, Alzheimer Drug Discovery Foundation, Bristol-Myers Squibb, GlaxoSmithKline, Institute IPSEN, Lundbeck, ... MedPage Today Laser + Skin Institute Dermatology Center Wants You to Look Your Best and ... - 14 Nov 2009 Dress for Success, the not-for-profit organization that helps disadvantaged women succeed in the workforce, has partnered with Allergan, the makers of Botox ... PR-USA.net (press release) Allergan 3Q Profit Rises 8.3% With Botox Help - Oct 29, 2009 Allergan Inc.'s (AGN) third-quarter profit rose 8.3% with help from rising Botox sales and while the company boosted ... Wall Street Journal Spectrum Pharmaceuticals Announces Third Quarter 2009 Corporate Update ... - Nov 12, 2009 ...million – $4.7 million from ZEVALIN and $0.3 million from FUSILEV ® – and $2.1 million attributable to the amortization of the Allergan licensing fee. ... WELT ONLINE Allergan, Inc. - SWOT Analysis - Aarkstore Enterprise - Nov 8, 2009 Allergan is a global health care company engaged in discovery, development and commercialization of specialty pharmaceutical and medical device products for ... PRMinds (press release) Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Acular(R) Ophthalmic ... - Nov 6, 2009 This strength of ketorolac is therapeutically equivalent to Acular® Ophthalmic Solution, 0.5%, from Allergan, Inc. Ketorolac tromethamine ophthalmic ... CNNMoney.com (press release) Medicis, Allergan fight for wrinkle-fighting consumers - Nov 10, 2009 That leaves the field wide open from the two remaining wrinkle-fillers: Juvederm, from Botox-maker Allergan; and Restylane, from Medicis. ... FiercePharma Allergan wins ruling in patent case against 2 drugmakers - Oct 25, 2009 TEL AVIV (MarketWatch) -- Allergan Inc. won a ruling in federal court that its patents on Alphagan, which lowers pressure in ... MarketWatch Allergan Claims Victory in Patent Suit Over Generics - Nov 7, 2009 Irvine's Allergan Inc. has won a pair of patent lawsuits over one of its eye drugs. Late last month, Allergan said a federal judge ruled that ... Orange County Business Journal Allergan Marketing Spurs Sales, Snags - Nov 6, 2009 In the third quarter, Irvine drug maker Allergan Inc. saw a big jump in selling costs as it spent an extra $35 million or so on ads for its ... Orange County Business Journal Bausch & Lomb, Allergan go Forward - Nov 2, 2009 Eye-care company Bausch & Lomb will implement Phase Forward's InForm electronic data capture solution and Allergan has also signed on with the integrated ... FierceBiotech IT Allergan Inc. (AGN) EVP, Fin & Bus. Dev., CFO Jeffrey L Edwards sells 32592 Shares - Nov 9, 2009 Dev., CFO of Allergan Inc. (AGN) Jeffrey L Edwards sells 32592 shares of AGN on 11/06/2009 at an average price of $59.27 a share. Allergan Inc. has a market ... GuruFocus.com Allergan Victory in ALPHAGAN® P Patent Infringemet Suit - Oct 27, 2009 The United States District Court for the District of Delaware handed Allergan, Inc. (NYSE:AGN) a victory last week in its patent infringement lawsuit ... IPWatchdog.com Personal Health: News and Notes - Nov 2, 2009 But Allergan Inc. advertised Latisse as "an historic innovation in eyelash enhancement." At least, it did until the FDA made the company correct its ... Philadelphia Inquirer Pharma earnings recap: Mylan, Allergan, Novo-Nordisk - Oct 30, 2009 Meanwhile, Allergan (NYSE: AGN), keeps owing its success to Botox as the anti-wrinkle drug rebounded and helped offset 11 percent lower sales of medical ... BloggingStocks (blog) Allergan Inc. Reports Operating Results (10-Q) - Nov 6, 2009 Allergan Inc. is a provider of eye care and specialty pharmaceutical products throughout the world with products in the eye care pharmaceutical ophthalmic ... GuruFocus.com Allergan wins brimonidine patent infringement case - Nov 4, 2009 Irvine, CA—The US District Court for the District of Delaware has ruled in favor of Allergan Inc. in its patent infringement lawsuit against two sets of ... ModernMedicine Spectrum Enters $151M Cancer Drug Collaboration with Nippon - Nov 10, 2009 For the US, Canada and Europe, Spectrum has partnered apaziquone with Allergan Inc. under a 2008 agreement. As part of that $345 million deal, Allergan ... Therapeutics Daily (press release) (registration) Allergan announces Horizon Grant recipients for clinical research in ophthalmology - Nov 4, 2009 Allergan announced recipients of Horizon Grants, which are awarded annually to support clinical research in the diagnosis or treatment of glaucoma, ... OSN SuperSite Allergan's First Amendment Case: REMS vs. Off-Label Promotion – and DTC - Oct 23, 2009 Allergan filed suit against the Food & Drug Administration on Oct. 1, challenging the prohibition of off-label promotion of prescription drugs in the ... The IN VIVO Blog (blog) Allergan wins patent infringement suit over generic versions of brimonidine - Oct 30, 2009 A US district court ruled in favor of Allergan in a patent infringement suit filed against companies aiming to market generic versions of Alphagan, ... OSN SuperSite Dexamethasone implant a first for macular edema after retinal vein occlusion - Nov 10, 2009 Ozurdex (Allergan) is now on the market and available for ophthalmologists to treat patients with retinal vascular occlusions (RVO).While the technology and ... Gerson Lehrman Group SADIF Analytics releases new summary due diligence report for Allergan, Inc. - Oct 20, 2009 2009-10-20 14:49:05 - SADIF-Investment Analytics has applied its StockMarksâ„¢ stock-rating system to Allergan, Inc. and produced a report, ... PR-Inside.com (Pressemitteilung) The Lowe Law Firm Files Suit over Alleged Botox Overdose - Nov 6, 2009 In his claim against Allergan, the patient alleges that the drug maker defectively designed and formulated the Botox and failed to warn consumers of the ... Business Wire (press release) Akorn posts $5.1 million third-quarter net loss - Nov 10, 2009 In the release, Akorn also announced the launch of a generic version of Acular (ketorolac tromethamine ophthalmic solution, Allergan). ... OSN SuperSite Dodge & Cox Buys Carefusion Corp., Nokia Corp., Suntrust Banks Inc., Sells ... - Nov 13, 2009 Dodge & Cox initiated holdings in Allergan Inc.. Their purchase prices were between $45.36 and $58.18, with an estimated average price of $53.39. ... GuruFocus.com Inspire Pharmaceuticals Inc. Reports Operating Results (10-Q) - Nov 6, 2009 Allergan recorded revenue from net sales of Restasis of approximately $129 million and $107 million, respectively. In October 2009, Allergan revised its ... GuruFocus.com Allergan Q3 net earnings up - Nov 3, 2009 David Pyott, Allergan's chairman of the board and CEO, said: "We are pleased with our continued operational performance during the third quarter as our ... Trading Markets (press release) ACADIA Pharmaceuticals to Announce Third Quarter 2009 Financial Results on ... - Nov 2, 2009 ...candidate in Phase I for glaucoma, both in collaboration with Allergan, and AM-831 in IND-track development in collaboration with Meiji Seika Kaisha. ... WELT ONLINE Vista Optics hits 30 years - Nov 13, 2009 He had previously worked for Allergan Hydron Europe. After relocation to a new laboratory in Kent in 1982, Vista started producing its own range of ... Optician Online About this author: - Oct 28, 2009 Allergan (AGN) is expected to report Q3 earnings on Thursday, October 29 before the market open with a conference call scheduled for 11am ET. ... Seeking Alpha (blog) Pharma bracing for tougher FDA guidance on trials - Nov 2, 2009 Reig referred to a lawsuit filed by Allergan, of Irvine, Calif., in early October against the FDA, seeking to distribute information to physicians on the ... NJBIZ Dress for Success - Nov 11, 2009 Vanessa is spearheading the Express Success campaign with Allergan (the maker of BOTOX) to benefit the not-for-profit organization by providing it with a ... MyFoxOrlando.com Botox Profits Rise: In Spite of or Because of the Dysport Competition? - Nov 4, 2009 Did Allergan's profit rise in spite of Dysport, or because of it? Both products work in the same manner. They are injected into key wrinkle causing muscles ... American Health and Beauty (press release) Another Gem From a 2000 Page Bill: 'Botox Carve-Out' Survives in PelosiCare Bill - Nov 13, 2009 ...out of the hands of terrorists, it would also give Irvine, California-based Allergan a special buffer even more generous than its biotech counterparts. ... Big Government (blog) ACADIA Pharmaceuticals, Inc. Q3 2009 Earnings Conference Call - Nov 9, 2009 While Pimavanserin is our most advanced product candidate, ACADIA also has other important programs in its pipeline through our collaborations with Allergan ... Seeking Alpha (blog) FDA's Risk Mitigation Rules Are Opening a Pandora's Box - Nov 6, 2009 And Allergan recently showed us one of them. Under the FDA Amendments Act of 2007, the agency was given broad discretion on requiring a formal REMS plan ... Therapeutics Daily (press release) (registration) Plastic Surgery Conference Encourages Mingling, Marketing, Learning - Oct 24, 2009 Dr. Mitchell Brown is one of the presenters for the Allergan Academy, a special after hours session on Saturday night, sponsored by Allergan, Inc. “This is ... The Plastic Surgery Channel Licensing Executives Society Announces 2009 Deals of Distinction Awards - Oct 21, 2009 Consumer Products Sector: Allergan and the Clinique Laboratories, LLC Allergan, Inc. and Clinique Laboratories, LLC partnered to produce a new line of ... Reuters Lumigan X EU Committee Recomendation - Oct 28, 2009 Lumigan X offers Allergan a new formulation to compete against generic versions of its glaucoma drug Lumigan after patent protection for Lumigan expires ... Gerson Lehrman Group Caraco releases seasonal allergic conjunctivitis treatment - Nov 9, 2009 ...to seasonal allergic conjunctivitis. The drug is a generic version of Allergan's Acular, which has sales of about $40 million a year, according to Caraco. Drug Store News (blog) European authorities recommend granting Lumigan marketing approval in Europe - Oct 23, 2009 MARLOW, UK — The Committee for Medicinal Products for Human Use (CHMP) has recommended granting Allergan marketing authorization for a 0.01% formulation of ... OSN SuperSite Phase Forward execs: Business good now and getting better - Oct 29, 2009 During the quarter, Phase Forward signed Allergan, a Southern California specialty healthcare manufacturer, to a multi-million-dollar, multi-year service ... Mass Device blogs (blog) Best Professional Sales Aid - Oct 29, 2009 Allergan made great use of customer insights and attention-grabbing design with this professional sales aid for Sanctura XR, offering docs the promise of ... Medical Marketing and Media Watch out for eyelash drug - Oct 27, 2009 The Food and Drug Administration is now looking into Latisse and in September warned Allergan, its maker, that promotional materials on the drug's Web site ... Quad City Times Spectrum Pharmaceuticals and Nippon Kayaku Collaborate to Develop Apaziquone ... - Nov 13, 2009 Spectrum Pharmaceuticals said that it has previously entered into a strategic collaboration with Allergan, Inc. for North America, Europe, and other key ... Trading Markets (press release) Preemption in action - Oct 20, 2009 A federal judge in Arizona tosses a product liability lawsuit against Allergan over a defective breast implant, ruling that its approval by the Food & Drug ... Mass Device blogs (blog) New Report Just Published Allergan Inc - Detailed Product Pipeline - Nov 11, 2009 ...(live-PR.com) - Reportlinker.com announces that a new market research report related to the Pharmaceutical industry is available in its catalogue. contain ... Live-PR.com (Pressemitteilung) Pacific Union welcomes Faxstein to Napa office - Nov 5, 2009 Faxstein was previously a marketing director and business director for Johnson & Johnson and also served as international marketing director for Allergan. ... Napa Valley Register Jonathan Richman to Speak at FDA Public Hearing on Promoting Medical Products ... - Nov 12, 2009 The agency's client list includes several FORTUNE 500 companies, such as Procter & Gamble, Abbott Nutrition, ConAgra Foods, Allergan, and Kroger. ... PR Newswire (press release) Allergan, Inc. - Medical Equipment - Deals and Alliances Profile - new report ... - Nov 10, 2009 Allergan operates through two reportable segments, namely, Specialty Pharmaceuticals and Medical Devices. The company's products are sold and distributed in ... PR-Inside.com (Pressemitteilung) Implant Approval Buoys Allergan, Mentor - Nov 20, 2006 By Robert Steyer. Allergan (AGN - commentary - Cramer's Take) and Mentor (MNT - commentary - Cramer's Take) saw their shares jump Monday after both won long ... TheStreet.com - TheStreet.com (subscription) FDA Gives Allergan Frown Lines - Feb 8, 2008 Allergan shareholders would grimace at Friday's falling stock prices if their Botox-injected faces would let them. Allergan (nyse: AGN - news - people ... Forbes Allergan Makes a Bid for Implant Maker - Nov 16, 2005 By BARNABY J. FEDER. Allergan, a company best known for eye-care products and its Botox antiwrinkle therapy, said yesterday that it had offered a $3.2 ... New York Times Allergan expands bladder role with Esprit deal - Sep 19, 2007 By Ransdell Pierson. NEW YORK, Sept 19 (Reuters) - Allergan Inc (AGN.N), which is testing its blockbuster anti-wrinkle drug Botox as a treatment for ... Reuters FDA approves Allergan's drug for longer eyelashes - Dec 26, 2008 Allergan said it estimates global peak sales of Latisse solution could top $500 ... Though not reported in clinical studies, Allergan said Latisse may also ... Reuters Allergan, Mentor Win Approval of Silicone Implants - Nov 17, 2006 By [bn:PRSN=1] Avram Goldstein [] and [bn:PRSN=1] Justin Blum []. Nov. 17 (Bloomberg) -- Silicone breast implants, made by Allergan Inc. and Mentor Corp., ... Bloomberg California and the West; Allergan's Inamed Bid Is Said to Outdo Rival'... - Dec 7, 2005 Inamed also said Allergan had put forth a revised offer and agreement that were ... But Inamed said it would remain neutral on the Allergan offer, ... Pay-Per-View - Los Angeles Times - ProQuest Archiver Patent lawsuit filed by Allergan; The company alleges that its … - Nov 20, 2007 Allergan Inc., the maker of the glaucoma treatment Lumigan, sued seven companies it said were improperly selling related products as ways to grow eyelashes. ... Pay-Per-View - Los Angeles Times - ProQuest Archiver FDA says Allergan drug enhances eyelashes - Dec 3, 2008 By MATTHEW PERRONE, AP Business Writer. Federal regulators on Wednesday said a glaucoma drug from Allergan appears to make eyelashes longer and fuller, ... FOXNews FTC Clears Allergan Merger | Medical Services | Financial Articles & ... - Mar 8, 2006 By Robert Steyer 03/08/06 - 01:54 PM EST. Allergan (AGN Quote) said Wednesday that it received approval from the Federal Trade Commission to complete its ... TheStreet.com - TheStreet.com (subscription) Allergan to acquire Inamed in $3 billion deal - MarketWatch - Dec 21, 2005 By MarketWatch. NEW YORK (MarketWatch) -- Allergan Inc. and Inamed Corp. Tuesday evening said they have agreed for Allergan to buy breast implant maker ... MarketWatch Allergan exec says deal to bolster obesity biz - Feb 22, 2007 By Julie Steenhuysen. CHICAGO (Reuters) - Allergan Inc.(AGN.N), best known for Botox wrinkle treatments and silicone breast implants, on Thursday said it ... Reuters Botox Boosts Allergan - Sep 11, 2008 The drugmaker's shares soared on the news that its anti-wrinkle injection may also relieve headaches. Allergan picked a winner with Botox: It not only wipes ... Forbes Allergan reports lower 1Q profit - Apr 27, 2005 By Val Brickates Kennedy, MarketWatch. BOSTON (MarketWatch) - Healthcare conglomerate Allergan Inc. reported slightly lower first-quarter profits on ... MarketWatch Mixed Outlook From Allergan - Nov 1, 2006 By Althea Chang. Allergan (AGN - commentary - Cramer's Take), the company that makes the wrinkle treatment Botox, said its earnings took a hit from rising ... TheStreet.com - TheStreet.com (subscription) Drug regulators re-evaluating Botox's safety - Feb 9, 2008 Manufacturer Allergan Inc. estimates it will yield as much as $1.4 billion in 2008. ... Botox and Botox Cosmetic are products of Allergan Inc. of Irvine. ... San Francisco Chronicle Allergan says Botox works on chronic migraines - Sep 12, 2008 By Debra Sherman. CHICAGO (Reuters) - Allergan Inc said on Thursday that its popular Botox facial wrinkle-smoother worked as a treatment for adults ... Reuters India Novavax to terminate drug manufacturing agreement with Allergan - Oct 25, 2007 NEW YORK (Thomson Financial) - Novavax Inc. Thursday said it had agreed to terminate the manufacturing agreement it has with Allergan Inc. for Estrasorb in ... Forbes ALLERGAN ESTIMATES 2006 SALES AFTER ACQUISITION - Mar 28, 2006 Author: AP. Botox maker Allergan said Monday its 2006 sales would be between $2.81 billion and $2.95 billion, reflecting the biomedical company's recent ... $2.95 - San Jose Mercury News - NewsBank Allergan to Buy Inamed - Dec 22, 2005 By DOW JONES. Allergan, the maker of Botox, entered into a definitive agreement late Tuesday to buy the Inamed Corporation for $3.2 billion, wresting the ... New York Times Allergan wins appeals court ruling vs Apotex - Apr 12, 2007 BOSTON, April 12 (Reuters)- Allergan Inc. (AGN.N), which makes the wrinkle treatment Botox, said on Thursday that a US federal appeals court affirmed a ... Reuters FDA Panel Backs Allergan's Eyelash Enhancing Drug - Dec 5, 2008 Allergan, which makes Botox anti-wrinkle injections, has asked the Food and Drug ... However, the same panel voted 5-3 with one abstention that Allergan ... ABC News Glaxo to market Allergan's Botox in Japan, China - Oct 3, 2005 Allergan Inc. will license development and commercial rights of its anti-wrinkle ... Under the agreement, Allergan also will co-promote Glaxo's migraine ... Bizjournals.com Allergan profit jumps on demand for drugs, devices - Aug 1, 2007 NEW YORK, Aug 1 (Reuters) - Allergan Inc. (AGN.N) posted stronger-than-expected results on Wednesday on higher sales of its prescription drugs, ... Reuters … and the West; EARNINGS ROUNDUP; Allergan's Net Income Gets a Lift ... - Aug 3, 2006 Allergan Inc. said second-quarter earnings more than doubled on strong sales of ... Allergan said sales of Botox and the company's eye-care products both ... Pay-Per-View - Los Angeles Times - ProQuest Archiver Allergan says Botox works on chronic migraines - Sep 11, 2008 CHICAGO – Allergan Inc said Thursday that its popular Botox wrinkle-smoother worked as a treatment for adults suffering from chronic migraines, according to ... San Diego Union - Tribune - San Diego Union Tribune Allergan loses bid to reclassify dry-eye drug - MarketWatch - Jan 21, 2005 By Laura Gilcrest, MarketWatch. WASHINGTON (MarketWatch) -- Allergan Inc. has lost its legal bid to have the Food and Drug Administration reclassify the eye ... MarketWatch Allergan drug gets label extension Los Angeles Business from bizjourna... - Jun 26, 2007 The US Food and Drug Administration has approved label extensions for Allergan Inc.'s Juvederm Ultra and Ultra Plus, Allergan said Tuesday. ... Bizjournals.com Allergan, Mentor May Sell Silicone Implants in Canada - Oct 20, 2006 By Rob Waters. Oct. 20 (Bloomberg) -- Allergan Inc. and Mentor Corp., competitors selling surgical implants, won Canadian approval to sell silicone-filled ... Bloomberg Allergan to acquire QLT's Aczone Gel 5% for $150M - Jun 9, 2008 BOSTON (Thomson Financial) - Allergan Inc. Monday agreed to acquire QLT Inc.'s Aczone Gel 5% product for about $150 million. ... Forbes Allergan CFO Departure Won't Change Strategy - Aug 24, 2005 Standard & Poor's Equity Research maintained a "hold" rating on Allergan (nyse: AGN - news - people ) after the company said its chief financial officer, ... Forbes Allergan reports quarterly profit - May 2, 2007 NEW YORK, May 2 (Reuters) - Allergan Inc. (AGN.N), maker of medical devices and the Botox wrinkle treatment, on Wednesday reported a first-quarter profit, ... Reuters RealMoney Radio: Allergan's Face-Lift - Nov 20, 2006 But one drug stock that should go up is Allergan (AGN) , Jim Cramer said on ... "I believe Allergan may be in the early stages of an incredible run and is ... TheStreet.com - TheStreet.com (subscription) Allergan failed to warn of dangerous Botox side effects, lawsuit... - Jul 10, 2008 Adverse reactions to the popular wrinkle-erasing drug have been rare, its Irvine-based manufacturer says. By Lisa Girion, Los Angeles Times Staff ... Los Angeles Times |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |